Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: Results from 31031 women from the Bonn-region in West Germany

Oncology Reports

Volumn 13, Issue 5, 2005, Pages 915-922

  Bollmann, Reinhard ^a   Bankfalvi, Agnes ^c   Griefingholt, Harald ^a   Trosic, Ante ^a   Speich, Norbert ^b   Schmitt, Christoph ^b   Bollmann, Magdolna ^a  

^a UNIVERSITY OF BONN   (Germany)

^b IMoGen GmbH   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cervical screening; Cytology; DNA cytometry; HPV genotyping; ThinPrep

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CARCINOMA IN SITU; COHORT ANALYSIS; FEMALE; GENETICS; GENOTYPE; GERMANY; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADULT; CARCINOMA IN SITU; CERVIX UTERI; COHORT STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; GERMANY; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 18844413614     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.5.915     Document Type: Article

References (29)

1. Parkin DM, Bray FI and Deves SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 37: 4-66, 2001.
2. Working group of population-based cancer registries in Germany: Krebs in Deutschland: Häufigkeiten und Trends. www.rki.de/KREBS, 2004.
3. Schenck U and von Karsa L: Cervical cancer screening in Germany. Eur J Cancer 36: 2221-2226, 2000.
4. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD and Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132: 810-819, 2000. (Pubitemid 30317797)
5. Diaz-Rosario LA and Kabawat SE: Performance of a fluid-based, thin-layer papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch Pathol Lab Med 123: 817-821, 1999. (Pubitemid 29409546)
6. Schiffman MH, Bauer HM, Hoover RN, et al: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85: 958-964, 1993. (Pubitemid 23177581)
7. Bosch FX, Manos MM, Munoz N, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802, 1995.
8. Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 1-3, 1999.
9. Sherman ME, Lörincz AT, Scott DR, et al: Baseline cytology, human papillomavirus testing and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95: 46-52, 2003. (Pubitemid 36124295)
10. Kjaer SK, van den Brule AJ, Paul G, et al: Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325: 1-7, 2002.
11. Bollmann R, Bollmann M, Henson DE and Bodo M: DNA cytometry confirms the utility of the Bethesda system for the classification of Papanicolaou smears. Cancer 93: 222-228, 2001. (Pubitemid 32552846)
12. Bollmann M, Bánkfalvi A, Trosic A, Speich N, Schmitt C and Bollmann R: Can we detect cervical human papillomavirus (HPV)-infection by cytomorphology alone? Diagnostic value of non-classic cytological signs of HPV effect in minimally abnormal Pap tests. Cytopathology (In press).
13. Speich N, Schmitt C, Bollmann R and Bollmann M: Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the West German area. J Med Microbiol 53: 125-128, 2004. (Pubitemid 38223691)
14. Bollmann R, Mehes G, Torka R, Speich N, Schmitt C and Bollmann M: Determination of features indicating progression in atypical squamous cells with undetermined significance: human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples. Cancer 99: 113-117, 2003. (Pubitemid 36529733)
15. Bollmann R, Mehes G, Torka R, Speich N, Schmitt C and Bollmann M: Human papillomavirus typing and DNA ploidy determination of squamous intraepithelial lesions in liquid-based cytologic samples. Cancer 99: 57-62, 2003. (Pubitemid 36267968)
16. Soost HJ: Befundwiedergabe in der gynäkologischen Zytodiagnostik -Münchener Normenklatur II. Gynäkol Prax 14: 433-438, 1990.
17. Bundesärztekammer: Leitlinie der Bundesärztekammer zur Qualitätssicherung zytologischer Untersuchungen im Rahmen der Früherkennung des Zervixkarzinoms. Deutsch Ärztebl 91: B298-B300, 1994.
18. Munoz N, Bosch FX, Sanjose S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003. (Pubitemid 36159887)
19. Laara E, Day NE and Hakama M: Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 30: 1247-1249, 1987. (Pubitemid 17070815)
20. Colgan TJ, Woodhouse SL, Styer PE, Kennedy M and Davey DD: Reparative changes and the false-positive/false-negative Papanicolaou test: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 125: 134-140, 2001. (Pubitemid 32096198)
21. Renshaw AA. Young NA, Birdsong GG, Styer PE, Davey DD, Mody DR and Colgan TJ: Comparison of performance of conventional and ThinPrep gynaecologic preparations in the College of American Pathologists Gynecologic Cytology Program. Arch Pathol Lab Med 128: 17-22, 2004. (Pubitemid 38049561)
22. Becker N: Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol 129: 691-702, 2003.
23. Lörincz A and Richart RM: Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 127: 959-968, 2003. (Pubitemid 36994855)
24. Franco EL: Primary screening of cervical cancer with human papillomavirus tests. JNCI Monographs 31: 89-96, 2003.
25. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al: Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20-25, 1999. (Pubitemid 29304297)
26. Melsheimer P, Vinokurova S, Wentzensen N, Bastert G and von Knebel Doeberitz M: DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res 10: 3059-3063, 2004. (Pubitemid 38619683)
27. Sathish N, Abraham P, Peedicayil A, Sridharan G, John S and Chandy G: Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Mol Diagn 8: 57-64, 2004. (Pubitemid 38989474)
28. Bibbo M, Dytch HE, Alenghat E, et al: DNA ploidy profiles as prognostic indicators in CIN lesions. Am J Clin Pathol 92: 261-265, 1989. (Pubitemid 19228922)
29. Lorenzato M, Bory JP, Cucherousset J, et al: Usefulness of DNA ploidy measurement on liquid-based smears showing conflicting results between cytology and high-risk human papillomavirus typing. Am J Clin Pathol 118: 708-713, 2002. (Pubitemid 37046315)